| Literature DB >> 24843664 |
Masaru Sakurai1, Koshi Nakamura2, Katsuyuki Miura3, Toshinari Takamura4, Katsushi Yoshita5, Satoshi Sasaki6, Shin-Ya Nagasawa2, Yuko Morikawa2, Masao Ishizaki7, Teruhiko Kido8, Yuchi Naruse9, Yasushi Suwazono10, Hideaki Nakagawa2.
Abstract
AIMS/Entities:
Keywords: Cohort study; Epidemiology; Family history
Year: 2013 PMID: 24843664 PMCID: PMC4015662 DOI: 10.1111/jdi.12033
Source DB: PubMed Journal: J Diabetes Investig ISSN: 2040-1116 Impact factor: 4.232
Baseline characteristics of the 3,517 participants according to family history of diabetes
| No family history | Family history | ||
|---|---|---|---|
|
| 2,887 | 630 | |
| Women (%) | 41.7 | 43.9 | 0.303 |
| Age (years) | 46.3 ± 6.1 | 45.8 ± 6.0 | 0.051 |
| Body mass index (kg/m2) | 23.0 ± 3.1 | 22.9 ± 3.1 | 0.634 |
| Fasting plasma glucose (mg/dL) | 91.1 ± 9.2 | 91.7 ± 9.4 | 0.121 |
| Hemoglobin A1c (%) | 5.3 ± 0.3 | 5.4 ± 0.4 | 0.078 |
| Fasting insulin (μU/mL) | 4.9 (3.0–7.0) | 4.9 (3.3–7.0) | 0.915 |
| HOMA‐IR | 1.05 (0.70–1.60) | 1.06 (0.70–1.60) | 0.688 |
| HOMA‐B | 66.6 (46.5–94.7) | 65.0 (45.0–94.7) | 0.344 |
| Total cholesterol (mg/dL) | 207.9 ± 33.4 | 207.1 ± 33.3 | 0.592 |
| Triglycerides (mg/dL) | 85.9 (56.0–126.0) | 88.5 (58.0–128.0) | 0.248 |
| HDL‐cholesterol (mg/dL) | 62.4 ± 15.1 | 62.4 ± 16.5 | 0.993 |
| Systolic blood pressure (mm Hg) | 117.7 ± 18.8 | 116.3 ± 17.0 | 0.087 |
| Diastolic blood pressure (mm Hg) | 74.8 ± 13.4 | 73.9 ± 12.2 | 0.135 |
| Total energy intake (kcal/day) | 2,048 ± 600 | 2,036 ± 613 | 0.632 |
| Smoking status (%) | 0.084 | ||
| Never smoker | 56.8 | 52.0 | |
| Ex‐smoker | 8.6 | 9.5 | |
| Current smoker | 34.6 | 38.5 | |
| Alcohol consumption | 0.340 | ||
| Never | 31.9 | 35.1 | |
| Occasional | 14.9 | 15.3 | |
| Consumption <20 g/day | 26.9 | 26.1 | |
| Consumption ≥20 g/day | 26.3 | 23.5 | |
| Habitual exercise – yes (%) | 24.0 | 27.0 | 0.113 |
| Presence of metabolic abnormalities (%) | |||
| High fasting plasma glucose | 3.9 | 4.6 | 0.451 |
| Hypertension | 29.3 | 26.2 | 0.118 |
| Dyslipidemia | 24.4 | 25.3 | 0.666 |
| Hypercholesterolemia | 37.6 | 34.0 | 0.089 |
| Occupational class (%) | 0.038 | ||
| Non‐manual workers | 25.4 | 29.4 | |
| Manual workers | 74.6 | 70.6 |
Data are presented as n, mean ± standard deviation, geometric mean (interquartile range) or %.
P‐value for Student's t‐test for continuous variables and χ2‐test for categorical variables.
Incidence rate and adjusted hazard ratio for type 2 diabetes during the 7‐year follow up according to family history of diabetes in 3,517 Japanese men and women
| No family history | Family history | Father only | Mother only | Sibling only | ≥2 family members | |
|---|---|---|---|---|---|---|
|
| 2,887 | 630 | 299 | 181 | 75 | 75 |
| Cases | 166 | 62 | 20 | 25 | 8 | 9 |
| Person‐years of follow up | 16,465 | 3,631 | 1,765 | 1,027 | 402 | 437 |
|
Incidence rate | 10.1 | 17.1 | 11.3 | 24.3 | 19.9 | 20.6 |
| Hazard ratio (95% CI) | ||||||
| Model 1 | 1 (reference) | 1.82 (1.36–2.43) | 1.26 (0.79–2.01) | 2.60 (1.71–3.97) | 1.76 (0.86–3.58) | 1.98 (1.01–3.87) |
| Model 2 | 1 (reference) | 1.81 (1.36–2.43) | 1.21 (0.76–1.93) | 2.75 (1.80–4.19) | 1.91 (0.94–3.90) | 1.85 (0.95–3.62) |
| Model 3 | 1 (reference) | 1.78 (1.32–2.37) | 1.21 (0.76–1.93) | 2.56 (1.67–3.92) | 2.06 (1.01–4.20) | 1.95 (0.99–3.82) |
| Model 4 | 1 (reference) | 1.78 (1.33–2.38) | 1.21 (0.76–1.93) | 2.56 (1.67–3.92) | 2.05 (1.00–4.18) | 1.95 (0.99–3.81) |
| Model 5 | 1 (reference) | 1.84 (1.36–2.47) | 1.29 (0.80–2.08) | 2.56 (1.67–3.92) | 1.95 (0.95–4.00) | 1.98 (1.01–3.91) |
CI, confidence interval;
Model 1, adjusted for age and sex;
Model 2, adjusted for age, sex and body mass index;
Model 3, adjusted for Model 2 variables plus smoking, alcohol consumption, habitual exercise, occupational class, and presence of hypertension, dyslipidemia and hypercholesterolemia;
Model 4, adjusted for Model 3 variables plus total energy intake;
Model 5, adjusted for Model 4 variables plus homeostasis model assessment for insulin resistance.
Interactions between obesity, insulin resistance, lifestyle factors and family history of diabetes in the context of the incidence of diabetes in 3,517 Japanese men and women
| Family history | Incidence rate (/1,000 person‐years) | Adjusted‐HR (95% CI) | |||
|---|---|---|---|---|---|
| Sex | 0.344 | ||||
| Men | No family history | 1,682 | 13.5 | 1.00 (reference) | |
| Family history | 355 | 23.1 | 1.62 (1.14–2.28) | ||
| Women | No family history | 1,202 | 5.6 | 1.00 (reference) | |
| Family history | 278 | 10.7 | 2.39 (1.36–4.22) | ||
| Body mass index (kg/m2) | 0.687 | ||||
| <22 | No family history | 1,165 | 4.5 | 1.00 (reference) | |
| Family history | 262 | 6.4 | 1.75 (0.84–3.62) | ||
| 22.0–24.9 | No family history | 1,032 | 10.2 | 1.00 (reference) | |
| Family history | 223 | 19.8 | 1.83 (1.13–2.97) | ||
| ≥25 | No family history | 687 | 19.9 | 1.00 (reference) | |
| Family history | 148 | 34.1 | 1.81 (1.16–2.81) | ||
| Fasting plasma glucose (mg/dL) | 0.212 | ||||
| <110 | No family history | 2,773 | 6.8 | 1.00 (reference) | |
| Family history | 601 | 12.2 | 1.87 (1.31–2.67) | ||
| 110–125 | No family history | 114 | 123.6 | 1.00 (reference) | |
| Family history | 29 | 180.3 | 1.54 (0.88–2.70) | ||
| HOMA‐IR (tertiles) | 0.478 | ||||
| <0.9 | No family history | 990 | 5.2 | 1.00 (reference) | |
| Family history | 214 | 11.2 | 2.26 (1.17–4.36) | ||
| 0.9–1.4 | No family history | 950 | 8.2 | 1.00 (reference) | |
| Family history | 203 | 15.0 | 1.96 (1.12–3.43) | ||
| ≥1.5 | No family history | 808 | 19.2 | 1.00 (reference) | |
| Family history | 179 | 30.3 | 1.56 (1.03–2.38) | ||
| HOMA‐B (tertiles) | 0.495 | ||||
| < 53.0 | No family history | 906 | 15.4 | 1.00 (reference) | |
| Family history | 203 | 24.2 | 1.54 (0.98–2.42) | ||
| 53.0–83.5 | No family history | 939 | 8.8 | 1.00 (reference) | |
| Family history | 197 | 17.9 | 2.09 (1.24–3.50) | ||
| ≥83.6 | No family history | 906 | 6.8 | 1.00 (reference) | |
| Family history | 196 | 12.1 | 1.99 (1.06–3.76) | ||
| Smoking status | 0.584 | ||||
| Never/former smoker | No family history | 1,884 | 7.6 | 1.00 (reference) | |
| Family history | 389 | 13.5 | 2.00 (1.32‐3.05) | ||
| Current smoker | No family history | 997 | 14.8 | 1.00 (reference) | |
| Family history | 244 | 23.8 | 1.59 (1.06–2.40) | ||
| Alcohol drinking | 0.060 | ||||
| Never/occasional drinker | No family history | 1,349 | 7.5 | 1.00 (reference) | |
| Family history | 319 | 16.0 | 2.74 (1.75–4.29) | ||
| Regular drinker | No family history | 1,535 | 12.4 | 1.00 (reference) | |
| Family history | 314 | 18.7 | 1.44 (0.97–2.15) | ||
| Habitual exercise | 0.288 | ||||
| No | No family history | 2,192 | 10.0 | 1.00 (reference) | |
| Family history | 462 | 15.6 | 1.55 (1.09–2.20) | ||
| Yes | No family history | 692 | 10.3 | 1.00 (reference) | |
| Family history | 171 | 22.1 | 2.47 (1.43–4.27) | ||
| Presence of metabolic abnormalities | 0.835 | ||||
| No | No family history | 1,196 | 4.1 | 1.00 (reference) | |
| Family history | 285 | 8.1 | 1.99 (1.05–3.78) | ||
| Yes | No family history | 1,691 | 14.7 | 1.00 (reference) | |
| Family history | 345 | 25.2 | 1.73 (1.24–2.41) | ||
| Total energy intake (kcal/day, tertiles) | 0.526 | ||||
| <1,744 | No family history | 963 | 9.3 | 1.00 (reference) | |
| Family history | 216 | 9.4 | 1.48 (0.78–2.81) | ||
| 1,745‐2,194 | No family history | 952 | 8.8 | 1.00 (reference) | |
| Family history | 217 | 21.0 | 2.19 (1.34–3.59) | ||
| ≥2,195 | No family history | 969 | 12.0 | 1.00 (reference) | |
| Family history | 200 | 22.1 | 1.75 (1.10–2.80) | ||
| Occupational class | 0.485 | ||||
| Non‐manual worker | No family history | 732 | 5.4 | 1.00 (reference) | |
| Family history | 185 | 11.0 | 2.21 (1.05–4.67) | ||
| Manual worker | No family history | 2,155 | 11.5 | 1.00 (reference) | |
| Family history | 445 | 19.4 | 1.69 (1.23–2.33) | ||
Adjusted for age, sex, body mass index, smoking, alcohol consumption, habitual exercise, and presence of hypertension, dyslipidemia and hypercholesterolemia.
Metabolic abnormalities included hypertension, dyslipidemia and hypercholesterolemia. HOMA‐B, homeostasis model assessment for pancreatic β‐cell function; HOMA‐IR, homeostasis model assessment for insulin resistance.